pargyline has been researched along with 1-(4-methoxyphenyl)pyridinium in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campbell, KJ; Hattori, T; Takada, M | 1 |
| Hirata, Y; Nagatsu, T | 1 |
| Forno, LS; Irwin, I; Langston, EB; Langston, JW | 1 |
| May, T | 1 |
4 other study(ies) available for pargyline and 1-(4-methoxyphenyl)pyridinium
| Article | Year |
|---|---|
Regional localization of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) uptake: mismatch between its uptake and neurotoxic sites.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain; Injections, Intraventricular; Male; Mesencephalon; Motor Neurons; Pargyline; Pyridinium Compounds; Rats; Rats, Inbred Strains; Receptors, Cholinergic | 1991 |
Inhibition of tyrosine hydroxylation in rat striatal tissue slices by 1-methyl-4-phenylpyridinium ion.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Corpus Striatum; Dihydroxyphenylalanine; Hydroxylation; In Vitro Techniques; Male; Monoamine Oxidase; Pargyline; Pyridines; Pyridinium Compounds; Rats; Rats, Inbred Strains; Tyrosine | 1985 |
Pargyline prevents MPTP-induced parkinsonism in primates.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Brain Chemistry; Male; Neurons; Pargyline; Parkinson Disease, Secondary; Pyridines; Pyridinium Compounds; Saimiri; Substantia Nigra | 1984 |
1-Methyl-4-phenylpyridinium (MPP+) binds with high affinity to a beta-carboline binding site located on monoamine oxidase type A in rat brain.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Binding, Competitive; Brain; Carbolines; Cerebral Cortex; Harmine; Male; Monoamine Oxidase; Pargyline; Pyridinium Compounds; Rats; Rats, Wistar | 1993 |